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Abstract: 
Objective: Childhood body mass index (BMI) has been related to vascular structure and 
function. However, little is known about the differing contributions of fat and lean mass to this 
relationship. Our objectives were to relate the fat and lean mass (bone excluded) 
components of BMI (fat mass index (FMI) and lean mass index (LMI); mass (kg)/height (m)2) 
to vascular measures in pre-pubertal children. 
Approach and Results: In the UK Southampton Women’s Survey mother-offspring cohort, 
983 children had dual x-ray absorptiometry and vascular measurements at 8-9 years.  Using 
linear regression analyses, we found that most vascular measures were related to BMI, but 
fat and lean mass contributed differently. Systolic blood pressure was positively associated 
with both FMI (β=0.91 (95% CI: 0.52, 1.30) mm/Hg) and LMI (β=2.16 (1.47, 2.85) mmHg), 
while pulse rate was positively associated with FMI (β=0.93 (0.48, 1.38) b/min), but 
negatively associated with LMI (β=-1.79 (-2.59, -0.99) b/min). The positive relation between 
BMI and carotid intima media thickness was mainly due to a positive association with LMI 
(β=0.013 (0.008, 0.019) mm). Carotid-femoral pulse wave velocity (PWV), but not carotid-
radial PWV, was positively associated with FMI (β=0.06 (0.03, 0.09) m/s). For systolic blood 
pressure, carotid-femoral PWV and reactive hyperemia significant interactions indicated that 
the association with fat mass depended on the amount of lean mass.   
Conclusions: In pre-pubertal children, differences in vascular structure and function in 
relation to BMI probably represent combinations of adverse effects of fat mass, adaptive 
effects of body size and relatively protective effects of lean mass.  
 
 
Abbreviations 
BMI – Body mass index 
CVD – Cardiovascular disease 
FMI – Fat mass index 
LMI – Lean mass index  
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BP – Blood pressure 
cDC – Carotid distensibility coefficient 
cIMT – Carotid intima media thickness 
PWV – Pulse wave velocity 
FMD – Flow-mediated dilatation 
DXA – Dual x-ray absorptiometry 
 
 
 
Introduction 
In adults, measures of vascular structure and function are strong markers for risk of later 
cardiovascular disease (CVD).1-5 For CVD prevention, it is important to identify vascular 
damage at the earliest possible stage, and intervene, by reducing cumulative exposure to 
risk factors. Overweight and obesity are related to increased risk of CVD.6-8 Changes in 
several vascular CVD risk markers have been observed in children in relation to obesity.9 
These include non-specific markers such as increased systolic and diastolic blood pressure 
(BP) and pulse rate,10-14 but also structural changes in large arteries, such as carotid intima-
media thickness (cIMT), carotid distensibility or pulse wave velocity (PWV).15-17 Furthermore, 
variations in endothelial function measures, including flow-mediated dilatation (FMD) and 
reactive hyperemia, have also been observed in children and young adults.15, 18 However, 
there remains uncertainty about whether relations with BMI and obesity in children reflect 
early pathological changes or mainly represent physiological adaptations to growth and 
development.15 
Body mass index (BMI) is often used as a proxy measure for adiposity, i.e. fat mass, 
although increased lean mass (the combination of muscle and internal organs) also leads to 
an increase in BMI. If fat and lean mass are similarly associated with vascular risk markers, 
then BMI will predict these markers at least as well as these components of body 
composition separately. However, if fat and lean mass relate to vascular risk markers in 
different ways, or the impact of fat mass depends on the amount of lean mass, then analyses 
of BMI in relation to CVD risk in children may be misleading. This could have implications for 
preventive measures in early life.  
Several studies of single or small groups of vascular structure and function measures in 
relation to BMI and obesity have been conducted in children,9, 10, 12, 15-22 but an extensive 
range of simultaneous measurements on children before puberty has not been obtained. We 
therefore made comprehensive measures of vascular structure and function in a well-
characterized prospective cohort of 8-9-year old children. We investigated:  
1) associations of vascular structure and function with BMI;  
2) associations of vascular structure and function with the fat and lean mass components of 
BMI;  
3) whether the associations between fat mass and CVD risk markers depended on the 
amount of lean mass, i.e. interactions between lean and fat mass. 
 
Materials and Methods 
The data that support the findings of this study are available from the corresponding author 
upon reasonable request.  
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Study population 
The Southampton Women’s Survey is an ongoing, prospective cohort study of 12 583, 
initially non-pregnant, women aged 20–34 years, living in the city of Southampton, UK.23 
Assessments of lifestyle, diet and anthropometry were performed at study entry (April 1998–
December 2002). Women who subsequently became pregnant were followed through 
pregnancy and their offspring through infancy and childhood.  Here we focus on the follow-up 
of the children aged 8-9 years.   
 
Exposure variables 
At age 8-9 years, height was measured to the nearest 0.1 cm with a portable stadiometer 
(Leicester height measure; Seca); weight was measured to the nearest 0.1 kg using 
calibrated digital scales (Seca). Data were used to calculate BMI (weight (kg)/ height (m)2). 
Body composition was assessed by dual X-ray absorptiometry (DXA) by a bone densitometry 
technician using a Hologic Discovery instrument (Hologic Inc., Bedford, MA, USA). Fat and 
lean mass were derived from a whole body scan, using pediatric software. The total radiation 
dose for each scan was 4.7 microsieverts (pediatric scan mode). Fat mass index (FMI) was 
calculated as fat mass (kg) / height (m)2 and lean mass index (LMI) was calculated as non-fat 
mass (minus bone) (kg) / height (m)2. Hence, these two measures represents the fat- and 
lean mass components of BMI. 
 
Outcome variables 
Trained clinical personnel (research nurses, cardiac physiologists and vascular 
ultrasonographers) performed a wide range of vascular measures. Systolic and diastolic BP 
and pulse rate, using a Dinamap Critikon 8100 monitor and carotid IMT and distensibility, 
using a Philips iE33 dedicated vascular ultrasound system (Philips Healthcare, Guilford, UK) 
were measured once after 10-15 min rest, with the child supine with their head turned 45 
degrees to the right of the midline. The left carotid artery was imaged just proximal to the 
carotid bifurcation, in a longitudinal section, with the vessel horizontally positioned on screen. 
A video-captured sequence was acquired over 10 seconds, which included at least 4 cardiac 
cycles. The sequence should show a clearly defined intima on both anterior and posterior 
aspects of the vessel. Immediately after acquiring the optimum trace, the BP cuff (upper arm, 
same side) was inflated and systolic and diastolic BP and pulse rate were noted in mmHg 
and beats/min respectively. To calculate carotid IMT and distensibility the images and traces 
were analyzed using LIA software at a remote PC. cIMT was measured in mm and was 
calculated using the frame showing the minimum diastole, where the IMT structure would not 
be compressed by blood flow in the vessel. The maximum diameter was noted. This process 
was repeated three times and the software used the mean of these measures in the analysis. 
Carotid distensibility was determined by measuring the luminal diameter excursion from 
diastole to systole. The distensibility coefficient (cDC), which reflects intrinsic vascular wall 
elasticity, was calculated using lumen diameters (D) and blood pressures (P) in the equation 
((2x∆DxD)+ ∆D2)/(∆PxD2) to reflect relative change in cross-sectional area per 10-3 kPa 
change in BP from systole to diastole.24  
Arterial stiffness was recorded transcutaneously as the velocity of the pulse wave between 
two arterial pulse sites (pulse wave velocity (PWV)), using a Vicorder device (Skidmore 
Medical Limited, Bristol, UK). In this study PWV was assessed over two different pathways 
(carotid-femoral and carotid-radial). The child rested supine for 10-15 min, lying on a couch 
with the upper body tilted in a 30 degree angle. Real-time pulse-wave measures were 
recorded by placing sensor cuffs (left carotid suprasternal notch, the upper left thigh and left 
wrist), with the time delay between the two simultaneously measured cardiac cycles 
measured. Integral software processed the data to calculate the mean time difference 
between R-wave and pressure wave on a beat-to-beat basis over 10 s, and the PWV was 
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then calculated using the mean time difference and arterial path length between the two 
recording points. The mean of up to four PWV measurements was calculated. 
Measurements of flow mediated dilatation (FMD) and reactive hyperemia were obtained from 
the right brachial artery, 5–10 cm above the antecubital fossa, using high-resolution 
ultrasound (Acuson Aspen Ultrasound System, Mountain View, CA; USA) with a linear probe, 
attached to a computer with LIA capture facilities, with the probe held in a stereotactic clamp 
that allowed micrometer positional adjustment. First, the brachial artery was imaged 
(baseline). Brachial artery FMD was then induced by a 5 min inflation of a pneumatic cuff to 
200 mmHg, around the forearm immediately below the medial epicondyle, followed by rapid 
deflation using an automatic air regulator device. Brachial artery diameter was measured 
using edge detection software (Brachial Tools, MIA, IA, USA) from ECG-triggered ultrasound 
images captured at 3 s intervals throughout the 11 min recording protocol. Flow-mediated 
dilatation was expressed as the maximum percentage change in vessel diameter from 
baseline. In parallel, the magnitude of the flow stimulus (Velocity Time Integral (VTI)) and 
heart rate (HR) were recorded continuously by pulse wave Doppler. Reactive hyperaemia is 
expressed as percent change in flow, from baseline to maximum flow within 15 s of cuff 
deflation (RH%), and was calculated as [((VTI peak x HR peak) – (VTI baseline x HR 
baseline)) / (VTI baseline x HR baseline)] x 100.  
Covariates 
We used a Directed Acyclic Graph (Supplemental Figure I) to determine confounders to 
adjust for in the models. These were child sex, age, time spent doing sports activities (hours 
per week, by maternal interview) and socioeconomic status (as determined by maternal 
educational level in six categories from none to university degree or above). 
Ethics 
The SWS study was conducted according to the guidelines laid down in the Declaration of 
Helsinki and was approved by the Southampton and South West Hampshire Local Research 
Ethics Committee (08/H0502/95). Written informed consent was obtained from all 
participating women and by a parent or guardian with parental responsibility on behalf of 
each child. 
Statistical analyses: 
Statistical analyses were performed using Stata 14 (StataCorp. 2015. Stata Statistical 
Software: Release 14. College Station, TX: StataCorp LP.). Descriptive variables were 
summarized as frequencies with proportions (%), means with standard deviation (SD) or 
medians with interquartile ranges (IQR), and differences between boys and girls were 
explored using Chi-Squared tests for categorical variables and t-tests or Mann-Whitney rank 
sum tests for normally and non-normally distributed continuous variables respectively (Table 
1). We assessed associations between BMI and the outcome variables using linear 
regression models for each outcome separately (Table 2), first univariately and then adjusted 
for confounders. Last, we replaced BMI in the regression models with FMI and LMI (Table 3), 
first exploring univariate associations with FMI and LMI (Model 0), then in models just 
including FMI and confounders (Model 1), in models just including LMI and confounders 
(Model 2) and finally in models including both FMI and LMI and confounders (Model 3). In 
supplementary models interactions between the two main exposures (lean mass and fat 
mass indices) were assessed by adding a multiplicative interaction term. Interactions are 
illustrated in figure 1-3, showing marginal means from the linear regression model including 
an interaction term between the continuous variables fat mass index and lean mass index, 
adjusted for confounders. For illustrative purposes, in the graphs, LMI was fixed at 11.4, 
11.9, 12.4 and 13.1 kg/m2 and FMI was fixed at 2.9, 3.7, 4.6 and 5.8 kg/m2. These cutpoints 
are quintiles (i.e. values that divide the range of data into five equal parts).  Interactions 
between sex and the main exposures were explored both by running the fully-adjusted 
analyses, including interactions between the exposure and sex, and by running the analyses 
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stratified by sex, describing very similar results in boys and girls (Supplemental Figures II 
and III). Final regression models were therefore run using the total sample.  
 
A sub-sample of children also had DXA-measures of fat- and lean mass at 4 years and 6-7 
years of age. In order to create z-scores for growth, linear associations between age and 
each of fat mass, lean mass and height were adjusted for to create fat mass, lean mass and 
height measures independent of age for each of these three follow-up points.  From these, 
age-adjusted fat mass and lean mass indices were calculated.  Residual growth in fat mass 
index for child j is defined as the difference between observed fat mass index at time p 
(FMIpj) and predicted FMI at time p (𝐹𝑀?̂?). 𝐹𝑀𝐼𝑝𝑗̂  is obtained by regressing FMIpj on all 
previous FMI measurements: 
𝐹𝑀𝐼𝑝𝑗 =  𝛽0 + ∑ 𝛽𝑖𝐹𝑀𝐼𝑖𝑗 +  𝑒𝑗
𝑝−1
𝑖=1
 
Residual growth in fat mass index (FMIpj - 𝐹𝑀𝐼𝑝𝑗̂ ) is therefore the residual error (?̂?𝑗) and is 
the conditional growth relative to that predicted from all previous fat mass index 
measurements. The residual growth measurements are orthogonal to all preceding fat mass 
index measurements.  The same procedure was used to calculate residual growth in lean 
mass index. In this sample we were therefore able to explore whether the vascular outcomes 
at age 8-9 were associated with FMI and LMI at 4 years, and with conditional changes in FMI 
and LMI from 4 to 6-7 years and from 6-7 to 8-9 years. 
 
 
Results  
Study population and characteristics 
Among the 12,583 women recruited to the SWS, 3,158 women became pregnant and had a 
live singleton birth, constituting the total sample for the SWS cohort (Supplemental Figure IV, 
Flow chart). This cohort has been followed up several times since birth.23 Of these a sub-
sample of 1,216 children participated in the 8-9-year follow-up. Due to logistical challenges 
and the time-consuming nature of measurements, not all measures could be taken for all 
participants. Most had only one or two missing measures and 76% had seven complete 
measures or more, and at least one vascular measure was taken on 1,166 children. Of 
these, 983 children also had valid DXA-measurements of fat and lean mass, constituting the 
final sample for the present study. Of these, a sub-sample (n=398) of children also had DXA 
measures at 4 and 6-7 years of age. 
Maternal and child characteristics and child anthropometry, and DXA- and vascular 
measures are presented, for boys and girls separately in Table 1. Girls had less lean mass, 
but more fat mass than boys, and for several vascular outcomes there were significant sex 
differences. However, the relationships between LMI and FMI and the vascular outcomes 
(i.e. the increase or decrease in each of the vascular measures per unit change in LMI or 
FMI) were similar in boys and girls (Supplemental Figures II and III), and our main analyses 
were therefore performed in and results presented for the total sample. Boys and girls had a 
mean BMI z-score according to the UK-WHO BMI reference of 0.03 and 0.12 respectively, 
indicating that the sample is representative of a general UK child population. 
 
Traditional CVD-risk factors; blood pressure and pulse rate 
Systolic BP was positively associated with BMI (Table 2), FMI and LMI, but most strongly 
with LMI (Table 3). The highest systolic BPs were observed in children with both high fat and 
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lean mass. However, there was a significant negative interaction (p=0.03) between lean and 
fat mass, suggesting that the impact of having more fat mass decreased if the child had more 
lean mass (Figure 1a).  
Diastolic BP was also positively associated with BMI (Table 2) and FMI, but not with LMI 
after adjusting for FMI (Table 3). Hence, the highest diastolic BP was found in children with 
high fat mass, irrespective of their lean mass (Figure 1b).  
Pulse rate was not associated with BMI (Table 2). However, in the models including both FMI 
and LMI (Table 3, Model 3), we observed a strong positive association with FMI but a strong 
negative association with LMI. Consequently, the highest pulse rate was observed in children 
with low lean mass but high fat mass (Figure 1c). 
 
Measures of arterial structure and stiffness 
Carotid IMT was strongly positively associated with BMI (Table 2), but not with FMI (Table 3). 
Hence, the association with BMI was mainly due to a strong positive relation with LMI (Table 
3 and Figure 2a). Children with higher BMI also had less distensible carotid walls (lower 
cDC), due to a negative relation with both LMI and FMI. However, neither of these 
associations were significant when adjusting for each other and other covariates (Table 3 
and Figure 2b). 
Carotid-femoral PWV was positively associated with BMI (Table 2) and FMI (Table 3), but not 
with LMI. However, there was a strong positive interaction between LMI and FMI (p=0.001). 
Consequently, the lowest carotid-femoral PWVs were observed in children with high lean 
mass and low fat mass (Figure 2c). Carotid-radial PWV, on the other hand, was negatively 
associated with BMI (Table 2), due to a negative association with LMI, but was not 
significantly associated with FMI (Table 3). The lowest values were found in children with 
high lean mass (Figure 2d). Also, for this outcome, there tended to be a positive interaction 
between lean and fat mass, but this was of borderline significance (p=0.06).  
 
Measures of endothelial function 
FMD was neither associated with BMI (Table 2), nor with LMI (Table 3). However, there was 
a weak, but significant, positive association with FMI. Hence, the highest FMD was observed 
in children with high fat mass (Table 3, Figure 3a). Reactive hyperemia was also not 
associated with BMI (Table 2) or with LMI, but borderline negatively associated with FMI 
(Table 3). Moreover, there was a significant interaction (p=0.01) indicating that the adverse 
impact of increasing fat mass was larger, and highly significant, if the child had low lean 
mass (Figure 3b). The lowest (“most adverse”) reactive hyperemia were observed in children 
with low lean mass and high fat mass.  
Sub-sample analyses 
In our sub-sample of children with DXA measured at 4- and 6-7 years of age we found that 
both fat- and lean mass at age 4, and relative increases from 4 to 8-9 years of age were 
positively associated with increased systolic BP at age 8-9 (Supplemental Table I and II). 
Furthermore, increases in FMI between 4 and 6-7 years of age were associated with higher 
carotid-femoral PWV (Supplemental Table II). LMI at age 4 was negatively associated with 
carotid-femoral- and carotid-radial PWV, and relative increases in LMI between 6-7 and 8-9 
years of age also tended to be associated with lower carotid-radial PWV.  
 
Discussion 
8 
 
In 8-9-year-old children, we found that high FMI was associated with higher systolic and 
diastolic BP, pulse rate and carotid-femoral PWV, all of which are considered to be CVD risk 
factors, but also with higher childhood brachial FMD, which is generally thought to be 
advantageous. On the other hand, for the vascular outcomes systolic BP, carotid IMT, pulse 
rate and carotid-radial PWV the lean mass component of BMI seemed to play the more 
important role, and high LMI was associated with higher systolic BP and carotid IMT, but 
lower pulse rate and carotid-radial PWV. Moreover, for systolic BP, carotid-femoral PWV and 
reactive hyperemia, the association with fat mass depended on the amount of lean mass. 
Together, the findings suggest a relatively protective effect of lean mass.   
Adiposity as a CVD risk factor 
Our results confirm previous findings showing a relation between increased BMI and fat 
mass and CVD risk markers, including in young children.15, 17, 18, 25-30 The mechanisms 
underlying this effect of adiposity are still not fully understood, but could include increased 
cardiac output, blood pressure, sympathetic nervous activation, inflammation and insulin 
resistance.9, 31 In contrast, for FMD we observed a positive association with increasing fat 
mass, even after adjusting for sex, which is surprising given the strong relation between 
adiposity and lower FMD in adults,3 and also in some studies comparing obese and normal-
weight children.9 It is however in agreement with results from children in another large UK-
cohort (the ALSPAC study).15 In that study the authors suggested that such improved 
endothelial dependent dilatation in obese children may represent an adaptive response 
despite deleterious effects of obesity.  
Lean mass as a moderator of CVD risk  
BMI is often used as a proxy measure of fat mass, and associations between BMI and CVD 
risk markers are interpreted as indicating an adverse effect of adiposity. However, we found 
that for some vascular outcomes, such as systolic BP and carotid IMT, the positive 
associations with BMI were mainly related to the lean mass component. This is consistent 
with some studies in adults.32 It has been suggested that a positive association between lean 
mass and systolic BP and carotid IMT may be explained by a strong relation with stroke 
volume and hence cardiac output, possibly representing adaptations of the cardiovascular 
system to a larger body size.33 The increasing blood pressure will lead to increases in carotid 
IMT, resulting in remodeling of the medial layer in an attempt to preserve wall stress. In 
contrast to these findings, we observed that for other vascular measures, such as pulse rate, 
carotid-femoral PWV and carotid-radial PWV, the lowest and most advantageous values 
were found in children with high lean mass. Moreover, for some outcomes, namely systolic 
BP, carotid-radial PWV and reactive hyperemia, we found that the deleterious effect of 
increasing fat mass depended on the amount of lean mass. Together, these results may 
indicate a relatively protective effect of lean mass. The underlying mechanisms remain 
speculative, but could reflect higher lean mass representing more muscle and cardiac mass, 
better metabolic function in the periphery, or greater cardiovascular fitness and hence also a 
higher capacity to cope with increasing adiposity levels.  They may potentially also represent 
better arterial function due to increased cardiac output and sustained hyperemia (and 
therefore shear stress) present with increased tissue mass. High lean mass could be an 
innate trait, but could also be related to greater physical activity. Whatever the mechanistic 
explanation, these findings clearly suggest that, as a risk factor for CVD, adiposity should not 
be studied in isolation, and that lean mass also needs to be taken into account. These 
findings could also be in line with literature demonstrating that low lean mass (“thinness”) is 
associated with an increased risk of long-term cardio-metabolic disease and poorer 
prognosis, particularly if combined with fat gain.34-36 Further research is needed on whether 
interventions to promote cardiovascular and muscular fitness in children, in contrast to 
merely reducing adiposity, will be beneficial in reducing later risk of CVD. 
Pulse wave velocities over different pathways  
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In our study, PWV was measured over two different pathways: carotid-femoral (aortic) and 
carotid-radial (mainly brachial) arteries. Several studies have shown a positive association 
between increased BMI/fat mass and carotid-femoral PWV in children.9, 37, 38 However, we 
observed that when including lean mass and the interaction between lean and fat mass in 
the model, there was a negative relation between lean mass and carotid-femoral PWV, 
although a positive relation with fat mass. The ALSPAC study observed that BMI and 
adiposity measures were negatively associated with carotid-radial PWV.15, 19 Children with 
obesity are also more likely to have more lean mass. Our study shows that the observed 
negative relationship between BMI/fat mass and carotid-radial PWV is mainly related to the 
negative association with lean mass, which will only be apparent if lean mass is taken into 
account. As increased PWV is a measure of vascular stiffness and CVD risk, for both carotid-
femoral and carotid-radial PWV there seems to be a protective effect of having greater lean 
mass. Further, a significant adverse effect of fat mass was only observed for carotid-femoral 
PWV. As carotid-femoral PWV is generally considered to represent arterial stiffening in the 
elastic aorta, whereas carotid-radial PWV predominantly represents changes in the more 
muscular brachial artery, this could reflect that in children the influence of fat on arterial 
stiffness may differ somewhat between elastic and muscular arteries.  
It could be argued that some of the effect of FMI and LMI on PWV is mediated through 
accompanying changes in mean arterial pressure (MAP), as maintaining arterial patency and 
distensibility requires pressure. Although the aim of our study was to assess the total effects 
of FMI and LMI, adjusted for confounders, and not mediating effects, we have tried adjusting 
for MAP in our models. This produced only marginal changes to the results. This suggests 
that changes in MAP are not the main explanation for the observed associations.  
Sub-sample analyses showed that both fat and lean mass at age 4 and relative increases in 
fat- and lean mass from 4 years of age and onwards were associated with several vascular 
outcomes at age 8-9 years. This could indicate that some vascular changes and adaptations 
in relation to body size happen very early in life. There are studies suggesting that 
associations between body size and measures of vascular structure and function may even 
represent adaptations happening during fetal development.21 However, this has not been 
extensively investigated. 
 
Sex-differences 
In our study girls had higher, i.e. more adverse, systolic and diastolic BP, pulse rate and 
carotid-femoral PWV, while FMD and reactive hyperemia were higher, and hence more 
advantageous, than in boys. Sex-differences in BP and reactive hyperemia remained 
significant even when differences in body composition, and other confounders were taken 
into account (data not shown), while differences in carotid-femoral PVW and FMD 
disappeared. Some of these results are slightly different from those observed in some other 
studies in children.15, 19 and could be due to differences in age and pubertal status between 
studies, which may modify the relationship between body composition and vascular 
measures. Moreover, in our main analyses we did not find any interactions with sex, and 
supplemental stratified analyses showed  that the relationships between FMI and LMI and 
the vascular outcomes are similar in boys and girls. 
 
Strengths: 
This study has several strengths, the most important being an integrated and comprehensive 
set of cardiovascular outcomes, representing different aspects of cardiovascular structure 
and function, and ultimately of CVD risk. In addition, PWV was measured in two different 
arterial segments, revealing differences between elastic and muscular vessels which may 
reflect the differing effects of central versus peripheral vascular function in relation to body 
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composition. A major strength of the study was the ability to distinguish between the effects 
of fat and lean mass components of childhood BMI.  
Limitations: 
Limitations of the study include insufficient statistical power for exploring more subtle 
relationships and interactions, even though the data were derived from a large, well-
characterized cohort. Further work is required to understand the mechanistic basis of the 
observed relationships between body composition and CVD risk factors in children, and to 
dissect out those effects that are adaptive versus those that suggest early pathology. We 
adjusted for sports participation in our models, but except for pulse rate, this had very little 
effect on the results. However, child physical activity levels reported by a parent are known to 
be relatively weakly related to “real” physical activity level. Furthermore, as this variable 
primarily includes organized sports it will probably be only a crude measure of total and real 
physical activity level.  It should also be noted that, although nested in a large cohort study, 
these findings are mainly from one follow-up period and so are cross-sectional; hence causal 
relationships cannot be inferred. We did however have a sub-sample of children with DXA-
measures at 4 and 6-7 years of age, enabling us to assess longitudinal effects, but as this 
sub-sample was relatively small, we had limited statistical power to draw strong conclusions 
from these analyses.  
 
Conclusions: 
We found that most measures of vascular structure and function in 8-9-year old children 
were related to their BMI and fat mass. However, for some of these vascular outcomes the 
relations with BMI were mainly explained by the lean mass component. Moreover, whether 
the relations with fat- or lean mass were positive or negative differed between vascular 
outcomes. These results suggests that in pre-pubertal children, differences in structure and 
cardiovascular function in relation to BMI and adiposity do not only represent adverse effects 
of fat mass, but also combinations of adaptive effects of body size and protective effects of 
lean mass.  
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Highlights 
 In 8-9-year-old children, the fat mass component of BMI was associated with 
higher systolic and diastolic BP, pulse rate and carotid-femoral PWV. 
 However, for some vascular outcomes the lean mass component of BMI 
seemed to play the more important role, and high lean mass was associated 
with higher systolic BP and carotid IMT, but lower pulse rate and carotid-radial 
PWV.  
 Moreover, for systolic BP, carotid-femoral PWV and reactive hyperemia, the 
association with fat mass depended on the amount of lean mass, suggesting a 
relatively protective effect of lean mass.   
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Table 1. Maternal and child characteristics and vascular outcomes at age 8-9 years, by child sex. Numbers are 
mean (SD), median (IQR) or n (%). Differences between boys and girls are tested by unpaired t-tests, Mann-
Whitney rank sum tests or chi-square tests. 
   Boys (n=496)  Girls (n=487)  p 
Maternal factors      
 Educational level     0.3 
  None 8 (2%)  11 (2%)   
  CSE 34 (7%)  43 (9%)   
  O-levels 129 (26%)  131 (27%)   
  A-levels 168 (34%)  134 (28%)   
  HND 32 (6%)  38 (8%)   
  Degree 125 (25%)  128 (26%)   
 Primiparous 264 (53%)  257 (53%)  0.9 
 Pre-pregnant smoking 112 (23%)  115 (24%)  0.7 
 Pre-pregnant BMI (kg/m2)  24.4 (22.0, 27.6)  23.9 (21.8, 27.0)  0.2 
Child explanatory factors      
 Age (years) 9.2 (0.2)  9.2 (0.3)  0.5 
 Time spent doing sports (h/wk) 2.5 (1.0, 5.0)  2 (0.5, 4.0)  <0.001 
 Anthropometric measures      
  Height (cm) 135.8 (5.7)  135.3 (6.3)  0.2 
  Weight (kg) 29.5 (26.7, 33.5)  30.5 (27.1, 35.2)  0.03 
  BMI (kg/m2) 16.1 (14.9, 17.6)  16.5 (15.2, 18.6)  <0.001 
  BMI z-score (UK-WHO)* 0.03 (1.16)  0.12 (1.13)   
 DXA-measures      
  Total fat mass (kg) 6.3 (4.9, 8.6)  8.6 (6.8, 11.5)  <0.001 
  Total lean mass (kg) 23.2 (3.1)  22.1 (3.3)  <0.001 
  Fat mass index (kg/m2) 3.5 (2.7, 4.6)  4.8 (3.8, 6.2)  <0.001 
  Lean mass index (kg/m2) 12.6 (1.0)  12.0 (1.2)  <0.001 
Child vascular outcomes      
  Systolic BP (mmHg) 105.4 (9.1)  107.8 (9.6)  <0.001 
  Diastolic BP (mmHg) 54.3 (7.4)  57.6 (7.8)  <0.001 
  Pulse rate (bpm) 71.9 (9.6)  75.4 (10.4)  <0.001 
  cIMT (mm) 0.496 (0.067)  0.486 (0.076)  0.06 
  cDC (mm/10-3kPa) 64.8 (23.3)  68.2 (24.4)  0.04 
  Carotid-femoral PWV (m/s) 4.55 (0.55)  4.64 (0.60)  0.05 
  Carotid-radial PWV (m/s) 7.12 (1.02)  7.10 (0.89)  0.8 
  FMD (%) 6.50 (3.36)  7.15 (4.09)  0.02 
  Reactive hyperemia (%) 533 (235)  586 (252)  0.004 
*Mean BMI z-scores according to the modified UK-WHO BMI reference, adjusted for sex and age. 
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Table 2. Associations between child BMI (exposure) and nine vascular measures (outcomes) at age 8-9 years. 
Numbers are regression coefficients (β (95% CI)) for the associations between child BMI (kg/m2) and each of the 
vascular outcomes. 
  Univariate    Adj. model*  
  β (95% CI) p  Adj β (95% CI) p 
Systolic BP (mmHg)  1.41 (1.18, 1.63) <0.001  1.33 (1.11, 1.56) <0.001 
Diastolic BP (mmHg)  0.46 (0.26, 0.65) <0.001  0.40 (0.20, 0.60) <0.001 
Pulse rate (bpm)  0.24 (-0.02, 0.50) 0.08  0.14 (-0.12, 0.40) 0.3 
cIMT (mm)  0.003 (0.001, 0.004) 0.005  0.003 (0.001, 0.005) 0.003 
cDC (mm/10-3kPa)  -0.90 (-1.51, -0.28) 0.004  -0.94 (-1.56, 0.31) 0.003 
Carotid-femoral PWV (m/s)  0.04 (0.02, 0.05) <0.001  0.03 (0.02, 0.05) <0.001 
Carotid-radial PWV (m/s)  -0.03 (-0.06, 0.00) 0.03  -0.03 (-0.06, -0.01) 0.01 
FMD (%)  0.10 (-0.01, 0.21) 0.07  0.09 (-0.02, 0.20) 0.1 
Reactive hyperemia (%)  -3 (-10, 4) 0.4  -4 (-11, 3) 0.3 
 
*Adjusted for socioeconomic status (maternal educational level) and child sex, age and hours doing sports/week. 
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Table 3. Associations between child body composition (fat mass index (FMI) and lean mass index (LMI) (exposures)) and nine CVD risk markers (outcomes) at age 8-9 years. 
Numbers are regression coefficients (β (95% CI)) for the associations between child FMI and LMI (kg/m2) and each of the vascular outcomes. 
   Model 0 *    Model 1 †   Model 2 ‡   Model 3 §  
   β (95% CI) p  Adj β (95% CI) p  Adj β (95% CI) p  Adj β (95% CI) p 
Systolic BP (mmHg)*             
 FMI (kg/m2)  1.64 (1.33, 1.96) <0.001  1.58 (1.25, 1.92) <0.001     0.91 (0.52, 1.30) <0.001 
 LMI (kg/m2)  2.56 (2.00, 3.12) <0.001     3.05 (2.46, 3.63) <0.001  2.16 (1.47, 2.85) <0.001 
Diastolic BP (mmHg)             
 FMI (kg/m2)  0.73 (0.46, 0.99) <0.001  0.53 (0.25, 0.81) <0.001     0.42 (0.08, 0.75) 0.02 
 LMI (kg/m2)  0.29 (-0.19, 0.76) 0.2     0.77 (0.26, 1.27) 0.003  0.36 (-0.24, 0.96) 0.2 
Pulse rate (bpm)             
 FMI (kg/m2)  0.70 (0.34, 1.06) <0.001  0.37 (-0.01, 0.75) 0.06     0.93 (0.48, 1.38) <0.001 
 LMI (kg/m2)  -1.31 (-1.95, -0.68) <0.001     -0.88 (-1.56, -0.21) 0.01  -1.79 (-2.59, -0.99) <0.001 
Carotid IMT (mm)             
 FMI (kg/m2)  0.001 (-0.001, 0.004) 0.4  0.002 (-0.001, 0.004) 0.2     -0.002 (-0.005, 0.001) 0.1 
 LMI (kg/m2)  0.011 (0.007, 0.016) <0.001     0.011 (0.006, 0.016) <0.001  0.013 (0.008, 0.019) <0.001 
Carotid DC (mm/10-3 kPa)             
 FMI (kg/m2)  -0.69 (-1.54, 0.16) 0.1  -1.02 (-1.93, -0.12) 0.03     -0.48 (-1.56, 0.60) 0.4 
 LMI (kg/m2)  -2.58 (-4.08, -1.09) 0.001     -2.22 (-3.83, -0.61) 0.007  -1.75 (-3.68, 0.18) 0.08 
Carotid-femoral PWV (m/s)*             
 FMI (kg/m2)  0.06 (0.04, 0.08) <0.001  0.06 (0.03, 0.08) <0.001     0.06 (0.03, 0.09) <0.001 
 LMI (kg/m2)  0.03 (-0.01, 0.07) 0.1     0.04 (0.00, 0.08) 0.04  -0.01 (-0.05, 0.04) 0.7 
Carotid-radial PWV (m/s)             
 FMI (kg/m2)  -0.01 (-0.05, 0.02) 0.4  -0.02 (-0.06, 0.02) 0.3     0.02 (-0.02, 0.07) 0.3 
 LMI (kg/m2)  -0.10 (-0.16, -0.04) 0.002     -0.12 (-0.19, -0.05) <0.001  -0.14 (-0.22, 0.06) <0.001 
FMD (%)             
 FMI (kg/m2)  0.21 (0.06, 0.36) 0.008  0.19 (0.02, 0.36) 0.03     0.23 (0.03, 0.43) 0.03 
 LMI (kg/m2)  0.02 (-0.24, 0.28) 0.9     0.09 (-0.19, 0.36) 0.5  -0.12 (-0.45, 0.21) 0.5 
Reactive hyperemia (%)*             
 FMI (kg/m2)  -3 (-13, 8) 0.6  -8 (-19, 3) 0.2     -12 (-26, 1) 0.08 
 LMI (kg/m2)  -5 (-22, 12) 0.6     1 (-17, 19) 0.9   12 (-10, 34) 0.3 
*Model 0: Univariate associations between child LMI and FMI and each of the vascular outcomes 
†Model 1: Associations between child FMI and each of the vascular outcomes, adjusted for maternal education and child sex, age and hours doing sports/week 
‡Model 2: Associations between child LMI and each of the vascular outcomes, adjusted for maternal education and child sex, age and hours doing sports/week 
§Model 3: Associations between child FMI and LMI and each of the vascular outcomes, adjusted for maternal education and child sex, age and hours doing sports/week, and mutually adjusting 
for one another.  
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Figure legends 
Figure 1:  
Title: Associations between lean- and fat mass index and systolic BP (A), diastolic 
BP (B) and pulse rate (C). 
Figure 2: 
Title: Associations between lean- and fat mass index and carotid IMT (cIMT) (A) and 
carotid distensibility coefficient (cDC) (B), carotid-femoral PWV (C) and carotid-radial 
PWV (D). 
Figure 3: 
Title: Associations between lean- and fat mass index and brachial FMD (A) and 
brachial reactive hyperemia (B). 
Graphic abstract:  
Title: Associations between lean- and fat mass index and systolic BP (A), carotid IMT 
(cIMT) (B), carotid-femoral PWV (cfPWV) (C) and carotid-radial PWV (crPWV) (D). 
 
Figure legend Figure 1, 2, 3 and Graphic abstract: Values are marginal means 
from a linear regression model including an interaction term between fat mass index 
and lean mass index, adjusted for confounders. Lean mass index was fixed at 11.4, 
11.9, 12.4 and 13.1 kg/m2 and fat mass index was fixed at 2.9, 3.7, 4.6 and 5.8. 
These cut-off points are quintiles (i.e. values that divide the range of data into five 
equal parts).     
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Figure 1 
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Figure 2 
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Figure 3 
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SUPPLEMENTAL MATERIAL 
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Supplemental Figure I: Directed Acyclic Graph, showing the confounders chosen to 
adjust for in the models.  
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Supplemental Figure II (boys): Associations between lean- and fat mass index and 
systolic BP (A), carotid IMT (cIMT) (B), carotid-femoral PWV (cfPWV) (C) and 
carotid-radial PWV (crPWV) (D). 
 
Values are marginal means from a linear regression model including an interaction term between fat 
mass index and lean mass index, adjusted for confounders. Lean mass index was fixed at 11.7, 12.2, 
12.7 and 13.3 kg/m2 and fat mass index was fixed at 2.6, 3.1, 3.8 and 4.8. These cut-off points are 
sex-specific quintiles (i.e. values that divide the range of data for boys into five equal parts).     
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Supplemental Figure III (girls): Associations between lean- and fat mass index and 
systolic BP (A), carotid IMT (cIMT) (B), carotid-femoral PWV (cfPWV) (C) and 
carotid-radial PWV (crPWV) (D). 
 
Values are marginal means from a linear regression model including an interaction term between fat 
mass index and lean mass index, adjusted for confounders. Lean mass index was fixed at 11.0, 11.7, 
12.1 and 12.8 kg/m2 and fat mass index was fixed at 3.6, 4.4, 5.2 and 6.7. These cut-off points are 
sex-specific quintiles (i.e. values that divide the range of data for girls into five equal parts).      
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Supplemental Figure IV. Flow chart showing participating children in the 
Southampton Women’s Survey cohort selected for analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
BP = blood pressure; IMT = intima media thickness (max); cDC = carotid distensibility coefficient 
(change in diameter (mm) per unit change in BP (10-3 kPa)); PWV = pulse wave velocity; FMD = flow 
mediated dilatation (maximum % change in brachial artery diameter after cuff-deflation); Reactive 
hyperaemia = per cent change in flow from baseline to maximum flow within 15 s of cuff-deflation; 
DXA = dual x-ray absorptiometry. 
Participated in 8-9 year follow-
up 
n= 1216 
Have at least one vascular  
measurement 
n=1166 
Also have DXA-measurements 
of lean and fat mass 
n= 983 (study sample) 
Systolic BP: n =819 
Diastolic BP: n = 819 
Pulse rate: n = 818 
Carotid IMT: n =838 
cDC: n = 815 
Carotid-femoral PWV: n = 725 
Carotid-radial PWV: n = 737 
FMD%: n = 692 
Reactive hyperemia: n = 687 
 
Total SWS cohort (live-born, 
singleton birth) 
n= 3158 
Sub-sample with DXA-
measurements at 4 and 6-7 
years of age 
n=398 
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Supplemental Table I. Associations between lean mass index (LMI) at 4 years and conditional changes in LMI from 4 to 6-7 years and from 6-7 to 8-9 years, and vascular 
outcomes at age 8-9. Numbers are regression coefficients (β (95% CI)) for the associations between LMI measures and each of the vascular outcomes. 
   Unadjusted β (95% CI) P-value n Adjusted β (95% CI)* P-value n 
Systolic BP (mmHg)    332   331 
 4 year LMI (SDs)  1.18 (0.25, 2.11) 0.01  1.83 (0.83, 2.82) < 0.001  
 4 to 6-7 year LMI change (SDs)  1.40 (0.46, 2.34) 0.004  1.47 (0.56, 2.38) < 0.001  
 6-7 to 8-9 year LMI change (SDs)  3.31 (2.35, 4.27) < 0.001  3.78 (2.82, 4.73) < 0.001  
Diastolic BP (mmHg)    332   331 
 4 year LMI (SDs)  -0.92 (-1.76, -0.08) 0.03  -0.24 (-1.16, 0.68) 0.61  
 4 to 6-7 year LMI change (SDs)  0.17 (-0.68, 1.02) 0.69  0.28 (-0.57, 0.68) 0.52  
 6-7 to 8-9 year LMI change (SDs)  1.03 (0.17, 1.89) 0.02  1.16 (0.27, 2.04) 0.01  
Pulse rate (bpm)    332   331 
 4 year LMI (SDs)  -1.82 (2.88, -0.76) 0.001  -1.54 (-2.74,0.35) 0.01  
 4 to 6-7 year LMI change (SDs)  -0.61 (1.69, 0.47) 0.27  -0.52 (-1.61, 0.58) 0.35  
 6-7 to 8-9 year LMI change (SDs)  0.29 (-0.81, 1.38) 0.61  0.48 (-0.67, 1.62) 0.42  
IMT maximum (mm)    335   334 
 4 year LMI (SDs)  0.01 (0.00, 0.01) 0.15  0.01 (0.00, 0.01) 0.18  
 4 to 6-7 year LMI change (SDs)  0.00 (-0.01, 0.01) 0.87  0.00 (-0.01, 0.01) 0.96  
 6-7 to 8-9 year LMI change (SDs)  0.00 (-0.01, 0.01) 0.97  0.00 (-0.01, 0.01) 0.77  
cDC (mm/10-3 kPa)    331   330 
 4 year LMI (SDs)  -1.70 (-4.48, 1.08) 0.23  -0.53 (-3.65, 2.59) 0.74  
 4 to 6-7 year LMI change (SDs)  -0.59 (-3.42, 2.24) 0.68  -0.66 (-3.52, 2.20) 0.65  
 6-7 to 8-9 year LMI change (SDs)  -2.33 (-5.20, 0.54) 0.11  -3.49 (-6.50, -0.49) 0.02  
cfPWV (m/s)    307   306 
 4 year LMI (SDs)  -0.09 (-0.15, -0.02) 0.009  -0.08 (-0.15, -0.01) 0.04  
 4 to 6-7 year LMI change (SDs)  0.06 (0.00, 0.13) 0.05  0.06 (-0.01, 0.12) 0.09  
 6-7 to 8-9 year LMI change (SDs)  0.05 (-0.02, 0.11) 0.13  0.05 (-0.01, 0.12) 0.12  
crPWV (m/s)    316   315 
 4 year LMI (SDs)  -0.18 (-0.27, -0.08) < 0.001  -0.16 (-0.27, -0.05) 0.004  
 4 to 6-7 year LMI change (SDs)  -0.03 (-0.13, 0.07) 0.60  -0.03 (-0.13, 0.07) 0.59  
 6-7 to 8-9 year LMI change (SDs)  -0.10 (-0.19, 0.00) 0.04  -0.11 (-0.20, -0.01) 0.04  
FMD (%)    288   287 
 4 year LMI (SDs)  -0.08 (-0.51, 0.36) 0.73  -0.15 (-0.63, 0.33) 0.54  
 4 to 6-7 year LMI change (SDs)  0.00 (-0.42, 0.42) 0.98  -0.01 (-0.45, 0.43) 0.96  
 6-7 to 8-9 year LMI change (SDs)  0.31 (-0.12, 0.74) 0.15  0.32 (-0.45, 0.77) 0.16  
Reactive hyperemia (%)    285   284 
 4 year LMI (SDs)  -11(-41, 18) 0.45  7 (-25, 40) 0.66  
 4 to 6-7 year LMI change (SDs)  -31 (-61, -2) 0.04  -32 (-62, -2) 0.04  
 6-7 to 8-9 year LMI change (SDs)  -19 (-49, 11) 0.22  -15 (-45, 16) 0.35  
*Adjusted for maternal education and child sex, age and hours doing sports/week. Separate model for each outcome, each including three predictors (4 year, 4 to 6-7 year and 
6-7 to 8-9 year measurements) 
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Supplemental Table II. Associations between fat mass index (FMI) at 4 years and conditional changes in FMI from 4 to 6-7 years and from 6-7 to 8-9 years, and vascular 
outcomes at age 8-9. . Numbers are regression coefficients (β (95% CI)) for the associations between FMI measures and each of the vascular outcomes. 
   Unadjusted β (95% CI) P-value n Adjusted β (95% CI)* P-value n 
Systolic BP (mmHg)    332   331 
 4 year FMI (SDs)  2.06 (1.10, 3.02) < 0.001  1.85 (0.81, 2.90) 0.001  
 4 to 6-7 year FMI change (SDs)  2.46 (1.48, 3.45) < 0.001  2.75 (1.76, 3.73) < 0.001  
 6-7 to 8-9 year FMI change (SDs)  1.99 (1.04, 2.92) < 0.001  2.00 (1.06, 2.94) < 0.001  
Diastolic BP (mmHg)    332   331 
 4 year FMI (SDs)  0.89 (0.03, 1.76) 0.04  0.01 (-0.93, 0.94) 0.99  
 4 to 6-7 year FMI change (SDs)  1.15 (0.26, 2.04) 0.01  1.23 (0.35, 2.11) 0.006  
 6-7 to 8-9 year FMI change (SDs)  0.11 (-0.74, 0.96) 0.80  -0.16 (-1.00, 0.68) 0.70  
Pulse rate (bpm)    332   331 
 4 year FMI (SDs)  1.25 (0.14, 2.36) 0.03  0.78 (-0.45, 2.00) 0.21  
 4 to 6-7 year FMI change (SDs)  0.03 (-1.11, 1.17) 0.96  0.02 (-1.13, 1.17) 0.97  
 6-7 to 8-9 year FMI change (SDs)  0.72 (-0.37, 1.81) 0.19  0.49 (-0.61, 1.59) 0.38  
cIMT maximum (mm)    335   334 
 4 year FMI (SDs)  -0.01 (-0.01, 0.00) 0.05  -0.01 (-0.02, 0.00) 0.05  
 4 to 6-7 year FMI change (SDs)  -0.01 (-0.01, 0.00) 0.19  0.00 (-0.01, 0.00) 0.27  
 6-7 to 8-9 year FMI change (SDs)  0.00 (0.00, 0.01) 0.35  0.00 (0.00, 0.01) 0.39  
cDC (mm/10-3 kPa)    331   330 
 4 year FMI (SDs)  -1.03 (-3.91, 1.86) 0.48  -2.79 (-5.98, 0.40) 0.09  
 4 to 6-7 year FMI change (SDs)  -0.16 (-3.13, 2.82) 0.92  -0.51 (-3.50, 2.49) 0.74  
 6-7 to 8-9 year FMI change (SDs)  -0.87 (-3.71, 1.97) 0.55  -1.30 (-4.16, 1.56) 0.37  
cfPWV (m/s)    307   306 
 4 year FMI (SDs)  0.04 (-0.02, 0.10) 0.19  0.00 (-0.06, 0.07) 0.91  
 4 to 6-7 year FMI change (SDs)  0.13 (0.07, 0.20) < 0.001  0.14 (0.07, 0.20) < 0.001  
 6-7 to 8-9 year FMI change (SDs)  0.04 (-0.02, 0.10) 0.21  0.03 (-0.04, 0.09) 0.41  
crPWV (m/s)    316   315 
 4 year FMI (SDs)  0.03 (-0.07, 0.12) 0.56  -0.02 (-0.13, 0.08) 0.68  
 4 to 6-7 year FMI change (SDs)  -0.06 (-0.16, 0.04) 0.25   -0.07(-0.17,0.03 ) 0.17  
 6-7 to 8-9 year FMI change (SDs)  -0.04 (-0.14, 0.05) 0.37  -0.07 (-0.16, 0.03) 0.19  
FMD (%)    288   287 
 4 year FMI (SDs)  0.05 (-0.37, 0.47) 0.83  0.10 (-0.37, 0.57) 0.68  
 4 to 6-7 year FMI change (SDs)  0.22 (-0.22, 0.66) 0.34  0.22 (-0.23, 0.67) 0.33  
 6-7 to 8-9 year FMI change (SDs)  0.32 (-0.12, 0.75) 0.15  0.31 (-0.14, 0.75) 0.17  
Reactive hyperemia (%)    285   284 
 4 year FMI (SDs)  22 (-8, 51) 0.15  -0.2 (-32, 32) 0.99  
 4 to 6-7 year FMI change (SDs)  -19 (-50, 12) 0.23  -16 (-47, 15) 0.30  
 6-7 to 8-9 year FMI change (SDs)  -25 (-56, 6) 0.11  -30 (-61, 0) 0.05  
*Adjusted for maternal education and child sex, age and hours doing sports/week. Separate model for each outcome, each including three predictors (4 year, 4 to 6-7 year and 
6-7 to 8-9 year measurements) 
 
